Effectiveness of Thyme Honey in Management of Xerostomia in Post Radiation Cancer Patients

• Status: Completed
• Trial end date: 2021-06-20
• Target enrollment: 0
• Participant gender: All

Summary

Xerostomia is the most frequent complication among patients who receive radiotherapy (RT) . The prevalence of xerostomia has been reported to be from 73.5% to 93% (Kakoei S.,2012). Damage to normal tissues can result by radiotherapy as it is not selective to cancer cells, and so affecting the quality of life of patients. Honey is one of the methods studied by CIM for management of HNC treatment side effects due to its properties. (Brennan et al., 2002; Clarkson et al., 2007; Furness et al., 2011;Hackett et al., 2015).

Thyme honey is a new alternative for management of xerostomia, which is a propolis gel product. Thyme honey is a variety of monofloral honey made from the nectar and pollen of thyme flowers. It has a strong antioxidant, antibacterial, antifungal and immuno modulating health effects. Due to the high sugar concentration in honey, it is believed that its presence in the oral cavity has a sialogogue effect, stimulating the salivary glands to produce saliva.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University

Criteria

Inclusion Criteria:

• Patients referred to non-palliative head and neck radiotherapy

• Total dose of radiation received (50-70 Gy)

• Patients with complaint of xerostomia

• Age 25-65 years old

• Objective dry mouth score from ( 2-5)

• Subjective dry mouth score from (1-4)

• Undergoing radiotherapy for at least three weeks

• Can independently complete the questionnaire

Exclusion Criteria:

• Have confirmed systemic diseases or medications associated with xerostomia

• Have a known allergy to honey

• Patients who had salivary glands removal surgery

• Patients with salivary gland diseases or malignancy

• Vulnerable groups such as pregnant females, prisoners, mentally and physically handicapped individuals.